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Submitted 7 May 2010; accepted 7 May 2010I would like to congratulate Kimura and colleagues from
Saitama Medical Center in Japan on a well presented expe-
rience of 25 patients with renovascular hypertension treated
with surgical management over a 40-year period of time.
Renovascular hypertension is a rare problem usually treated
at specialized medical centers. Medical management has
been the standard therapy. Themain goal ofmedical therapy
is hypertension control and the prevention of renal damage.
In certain circumstances, surgical revascularization is
needed when medical treatment has failed, but the experi-
ence with surgical bypass in this age group is very limited.
The authors performed several different types of
bypasses for patients with Fibromuscular Dysplasia,
Takayasu’s Arteritis, and Neurofibromatosis type I. The
different types of reconstructions included aortorenal
bypass with a synthetic graft, autogenous conduit (vein and
internal iliac artery), or direct reimplantation. In addition,
two patients underwent primary nephrectomy for hyper-
tension control when reconstruction was not possible. There
was no peri-operative mortality in their experience,
including complex reconstructions performed prior to 1974.
There were only 3 early failures in their experience of
treating 29 renal arteries. At a mean follow-up of 24.4
months, 7 patients required secondary nephrectomy for
hypertension control due to graft failure. The need for
nephrectomy was more common in the prosthetic bypassDOI of original article: 10.1016/j.ejvs.2010.03.019.
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attributed to cardiovascular causes.
The manuscript is complex in its analysis due to the
extensive time period involved. The authors used prosthetic
bypasses until 1974. After this time, a paradigm shift was
made to autologous bypasses or direct implantation. This
decision was made due to the differences seen with short and
long-term patency in prosthetic bypasses as compared to the
useofnative tissueconduits ordirect implantation. Iwonder if
the same findings would exist with the current expertise in
surgical bypass techniques. In addition, peri-operative anti-
coagulation is different and the post-operative anti-platelet
therapy is markedly changed over time. Either way, it seems
appealing to use a native conduit when performing recon-
structions on children and adolescents.
Percutaneous solutions are becoming more widely
accepted throughout every vascular bed. I agree with the
author’s statement of caution for the use of renal artery
angioplasty to treat pediatric renovascular hypertension. FMD
may be the disease state that would respond well and would
be performed without adjunctive stenting. Future surgical
bypass would likely not be compromised if needed for recur-
rent disease and the development ofworsening hypertension.
I am impressed with this experience with surgical bypass
to treat pediatric hypertension. I think it highlights the
safety and efficacy of the procedure, especially with
autologous bypasses or direct implantation. Pediatricians
and pediatric cardiologists should not be reluctant to refer
patients to surgeons for definitive treatment of hyperten-
sion in children and adolescents.d by Elsevier Ltd. All rights reserved.
